Trial record 4 of 62 for:    Open Studies | "Bone Transplantation"

Comparative Efficacy of the Masquelet Versus Titanium Mesh Cage Techniques for the Treatment of Large Long Bone Defects

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2013 by The University of Texas, Galveston
Sponsor:
Collaborator:
Information provided by (Responsible Party):
The University of Texas, Galveston
ClinicalTrials.gov Identifier:
NCT02015390
First received: May 29, 2013
Last updated: December 12, 2013
Last verified: December 2013
  Purpose

The United States Department of Defense (DoD) is funding exciting new research at the University of Texas Medical Branch (UTMB) Department of Orthopaedic Surgery and Rehabilitation that can be a major improvement in the treatment of extremity trauma involving segmental bone loss. These devastating injuries occur frequently in both civilians and the military. They typically result from motor vehicle accidents, high-energy fractures, gunshot injuries, and blast injuries, but also from the surgical removal of a bone segment because of infection or tumor. Despite many modern medical advances in this area, bone healing that can adequately replace bone loss and restore pre-injury limb function is extremely difficult to achieve. Existing standard treatment procedures are exceedingly complicated, require highly specialized equipment and clinical skills, and usually require many surgical procedures over many months or years. Despite these effort and costs, major complications usually occur with all the standard treatment options, the patient's ability to return to an acceptable functional status is typically low, and, therefore, many of these patients have their limbs amputated.

The UTMB Department of Orthopaedic Surgery and Rehabilitation will conduct a DoD-funded clinical trial to determine and compare the advantages of two new and innovative surgical bone defect treatment techniques that can be significantly more effective for wounded warriors or civilian patients and with these conditions. One treatment method, called "the Masquelet Technique", involves two-stage surgery: the first one to create a biomembrane around the defect by applying a cement spacer, and then the second one for cement spacer removal and defect bone grafting. The other method, developed by UTMB physicians, is "the Cage Technique" and it comprises one-stage surgery in which a special hollow, fenestrated, titanium cage filled with bone graft is implanted in the defect. Initial clinical experience with both of these techniques has been very promising, but to date, there has been no prospective clinical study comparing the two new methods of defect treatment. Identifying an optimal surgical bone defect reconstructive technique would significantly improve the clinical outcomes of patients with these challenging conditions.


Condition Intervention
Segmental Long Bone Defects
Procedure: Iliac crest autogenous bone grafting
Procedure: Reamer-Irrigator-Aspirator autogenous bone grafting

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: The Comparative Efficacy of the Masquelet Versus Titanium Mesh Cage Reconstruction Techniques for the Treatment of Large Long Bone Deficiencies

Resource links provided by NLM:


Further study details as provided by The University of Texas, Galveston:

Primary Outcome Measures:
  • Defect Healing [ Time Frame: 12, 18 months ] [ Designated as safety issue: No ]
    Radiographic determination of bone defect healing (plain radiography, computed tomography)


Secondary Outcome Measures:
  • Functional outcomes [ Time Frame: 2 weeks, 6 weeks, 3 months, 6 months, 12 months, 18 months ] [ Designated as safety issue: Yes ]
    Pain (Brief Pain Inventory Short Form); Region-Specific Functional Assessment (Disabilities of the Arm, Shoulder, and Hand; Lower Limb Core Scale);Outcome Survey (Short-Form 36); Time Trade-Off to assess Quality-Adjusted Life Years; Adverse Event Monitoring


Estimated Enrollment: 30
Study Start Date: October 2013
Estimated Study Completion Date: October 2017
Estimated Primary Completion Date: October 2017 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: The Masquelet (biomembrane) defect reconstruction
The Masquelet defect reconstruction is a two-stage technique for the treatment of large segmental bone defects that involves the induction of a biomembrane about a poly(methylmethacrylate)(PMMA) cement spacer within the defect and, following cement removal, autogenous bone grafting of the defect while preserving the biomembrane. The typical time interval between the two stages is 6-8 weeks. The biomembrane not only assists in retaining the bone graft, but serves as a rich source of vascular supply and growth factors which constitute an excellent biological milieu for the graft to consolidate and heal the defect.
Procedure: Iliac crest autogenous bone grafting
Other Name: Cancellous bone grating harvested from the iliac crest
Procedure: Reamer-Irrigator-Aspirator autogenous bone grafting
Other Name: RIA harvested (from the femour) autogenous bone grafting
Active Comparator: Cylindrical titanium mesh cage defect reconstruction
The cylindrical titanium mesh cage technique is a single-stage surgical procedure that immediately restores limb anatomy and alignment, and provides limb stability sufficient enough for early, unrestricted mobilization while permitting bone and soft tissue healing. It involves the implantation of a fenestrated cylindrical titanium mesh cage packed with autogenous bone graft.
Procedure: Iliac crest autogenous bone grafting
Other Name: Cancellous bone grating harvested from the iliac crest
Procedure: Reamer-Irrigator-Aspirator autogenous bone grafting
Other Name: RIA harvested (from the femour) autogenous bone grafting

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Presence of an extremity long bone (femur, tibia, humerus, ulna, radius) segmental defect requiring surgical reconstruction with at least one of the following etiologies:

  • traumatic segmental bone defect that warrants surgical reconstruction;
  • acquired bony nonunion (not congenital) treatable by segmental resection and reconstruction;
  • local osteomyelitis (dormant or active) treatable by segmental bone resection and reconstruction;
  • localized, nonmalignant tumor with involvement of bone diaphysis treatable by segmental bone resection and reconstruction.

Exclusion Criteria:

  • Non-segmental defects (eg, defect in continuity involving only single cortex);
  • Inability or contraindications to achieve stabilization with an intramedullary (IM) nail;
  • Insufficient defect size (humerus defects <5 cm; femur or tibia defect <2 cm in length);
  • Extremity unsuitable for salvage;
  • Patients with inadequate neuro-vascular status;
  • Defect and/or soft tissue status ineligible for surgical reconstruction;
  • Ipsilateral extremity defect (eg, tibia and femur ipsilateral defects);
  • Skeletal immaturity (open growth plate and/or age <18 years);
  • Known allergic reaction to titanium implants;
  • Disseminated osteomyelitis throughout the bone;
  • Active systemic infection at time of surgery;
  • Congenital / genetic etiology of nonunion (congenital pseudoarthrosis, osteogenesis imperfecta, etc.);
  • Women who are pregnant or nursing;
  • Women who intend to become pregnant during the study followup (ie, 2 years);
  • Disseminated and/or nonresectable malignant tumor involving bone;
  • Patients with active compartment syndrome;
  • Prisoners;
  • Patients considered as non-compliant with medical and follow up care;
  • Patients using narcotics, abusing prescription drugs (within last 2 years);
  • Patients with alcohol abuse;
  • Patients deemed incapable of following instructions pertaining to post operative care due to mental or medical condition;
  • Patients deemed ineligible due to medico-social concerns.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02015390

Locations
United States, Texas
The University of Texas Medical Branch Recruiting
Galveston, Texas, United States, 77555
Contact: Zbigniew Gugala, MD,PhD    409-747-5760    zgugala@utmb.edu   
Contact: Ronald W Lindsey, MD    409-747-5700    rlindsey@utmb.edu   
Principal Investigator: Zbigniew Gugala, MD,PhD         
Principal Investigator: Ronald W Lindsey, MD         
Sponsors and Collaborators
The University of Texas, Galveston
  More Information

No publications provided

Responsible Party: The University of Texas, Galveston
ClinicalTrials.gov Identifier: NCT02015390     History of Changes
Other Study ID Numbers: 13-100, DoD OR120128
Study First Received: May 29, 2013
Last Updated: December 12, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by The University of Texas, Galveston:
bone defects
iatrogenic resection
titanium mesh cage
biomembrane
Masquelet technique

ClinicalTrials.gov processed this record on July 20, 2014